Stocks
Novartis (NVS) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 62.5% | 62.5% | 31.6% | 31.6% | 39.6% | 37.9% | ||
| Changes by years, y/y, % | +28pp | 0pp | -31pp | 0pp | +8pp | -0.7% | |||
Novartis. EBITDA margin, %
Novartis. EBITDA margin, changes, pp
Novartis (NVS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 37.5% | 34.6% | 40.4% | 35.5% | 41.8% | 37.9% | |
| Changes by years, y/y, % | +4pp | +4pp | +8pp | +6pp | +4pp | |||
| Changes by quarters, q/q, % | +8pp | -3pp | +6pp | -5pp | +6pp | |||
